Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00250783 · ClinicalTrials.gov registry record
Pre-Clinical Models in Gynecological Tumors A Tissue Repository
A clinical trial of Endometrial Neoplasms and Uterine Neoplasms, sponsored by University of New Mexi.
- Completed
- Registry status
- 26
- Enrollment target
- 1
- Study location
NCT00250783: Completed study of Endometrial Neoplasms and Uterine Neoplasms, sponsored by University of New Mexi.
NCT00250783 is a study of Endometrial Neoplasms and Uterine Neoplasms that has completed, run by University of New Mexi. The registered enrollment target is 26 participants, below the 374-participant average among 14 other Endometrial Neoplasms trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00250783, a study of Endometrial Neoplasms and Uterine Neoplasms, has completed, sponsored by University of New Mexi.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to provide a repository for long-term storage of endometrial cancer tumor and normal tissue, ascites and serum. This material will be used in studies to better understand the molecular biology of endometrial cancer.
Conditions Studied
Study Locations (1)
New Mexico
- University of New Mexico - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2002-07 |
| Est. Completion | 2008-01 |
What the finished NCT00250783 record still lists
NCT00250783 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 374-participant average among 14 other Endometrial Neoplasms trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Endometrial Neoplasms appearing as the primary indexed condition, and to 0 interventions.
NCT00250783 reports a single indexed study location in New Mexico.
Frequently Asked Questions
What is clinical trial NCT00250783 about?
NCT00250783 is a clinical study titled "Pre-Clinical Models in Gynecological Tumors A Tissue Repository". The purpose of this study is to provide a repository for long-term storage of endometrial cancer tumor and normal tissue, ascites and serum. This material will be used in studies to better understand the molecular biology of endometrial cancer.
What is the current status of trial NCT00250783?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2002-07. Estimated completion is 2008-01.
What conditions does trial NCT00250783 study?
This clinical trial studies the following conditions: Endometrial Neoplasms, Uterine Neoplasms.
Who is sponsoring clinical trial NCT00250783?
This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00250783 being conducted?
This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometrial Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00250783's enrollment target sits among peer trials
26 14th of 14 higher than 1 of 14 other Endometrial Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Endometrial Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of LY4175408 in Participants With Advanced Cancer
RECRUITING · Phase 1
-
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RECRUITING · Phase 1
-
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RECRUITING · Phase 1
-
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
RECRUITING · Phase 1
-
A Study of DM002 in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia